OPA Addiction Day 2019
2019-09-28 2019-09-28 OPA Addiction Day 2019 Ontario Psychiatric Association America/New_York

Organization: OPA
CME Accreditation: Mainpro+

A Primer for Working with People Using Substances

Date: Saturday, September 28, 2019

Venue: Li Ka Shing Knowledge Institute at St. Michael’s Hospital, Room 136 (209 Victoria Street, Toronto)

This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the Continuing Education and Professional Development Office at the Northern Ontario School of Medicine for up to 6.25 Mainpro+ credit(s).

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Continuing Education and Professional Development Office at the Northern Ontario School of Medicine. You may claim a maximum of 6.25 hour(s) (credits are automatically calculated).

Conference Chairs:

Valerie Primeau MD, FRCPC, Head of Service of General Psychiatry at North Bay Regional Health Centre, North Bay RAAM Physician Lead, North Bay DAVINCI Physician Lead, Wiplove Lamba MD, FRCPC, Dip ABAM, ISAM (C) Addiction Psychiatrist at St. Michael’s Hospital

Small Group Moderators:

Valerie Primeau, Wiplove Lamba, Marlon Danilewitz, Anees Bahji, Narges Beyraghi, Sumeet Dama

Conference Planning Committee:

Valerie Primeau, Wiplove Lamba, Marlon Danilewitz, Anees Bahji, Narges Beyraghi, Sumeet Dama, Mike Franklin

Learning Objectives:

Upon attending the day, attendees will be able to 

  1. Compare and prescribe various pharmacotherapy options for people who use substances in both the withdrawal and maintenance phase, including opiate agonist treatment and anti-craving medications
  2. Apply psychotherapy principles for people who use substances, including motivational interviewing and behavioural health interventions
  3. Engage with an interprofessional team to discuss treatment approaches for complex patients presenting with concurrent disorders
Agenda:

08:30 – 09:00

Registration (Coffee and Snacks)

09:00 – 10:30

Pharmacotherapy Primer for the Treatment of Substance Use Disorders

10:30 – 10:45

Break

10:45 – 12:15

Small Group Case Discussion:

  • Management of Alcohol Use Disorder Withdrawal and Maintenance
  • Starting Buprenorphine
  • Integrated Treatment of Concurrent Disorders

12:15 – 13:00

Lunch

13:00 – 14:30

Introduction to Motivational Interviewing and Behavioural Approaches

14:30 – 14:45

Break

14:45 – 16:00

Concurrent Practical Sessions:

  • Practice Motivational Interviewing Skills
  • Discuss the Treatment of Complex Patient Presentations

16:00 – 16:30

Closing Remarks, Feedback and Evaluations

Pharmacotherapy Primer for the Treatment of Substance Use Disorders

Presenters: Dr. Valerie Primeau and Dr. Wiplove Lamba

Session Objectives:

By the end of this session, the participant will be able to:

  1. Apply strategies to diagnose and treat Substance Use Disorders
  2. Assess the indications, benefits and potential adverse effects of pharmacological agents when treating Substance Use Disorders
  3. Apply current principles for withdrawal management of common substances
Small Group Case Discussion

Moderators: Valerie Primeau, Wiplove Lamba, Marlon Danilewitz, Anees Bahji, Narges Beyraghi, Sumeet Dama

Session Objectives:

By the end of this session, the participant will be able to:

  1. Implement the management of Alcohol Use Disorder withdrawal and maintenance strategies
  2. Describe how to start buprenorphine for Opioid Use Disorder
  3. Institute an integrated approach in the treatment of concurrent disorders
Introduction to Motivational Interviewing and Behavioural Approaches

Presenters: Dr. Valerie Primeau and Dr. Wiplove Lamba

Session Objectives:

By the end of this session, the participant will be able to:

  1. Incorporate general psychotherapeutic approaches to the treatment of concurrent disorders and recognize the outcome-based benefits of trauma-informed care
  2. Apply common Motivational Interviewing techniques used in the treatment of Substance Use Disorders
  3. Implement an integrated approach in the treatment of concurrent disorders
Concurrent Practical Sessions

Moderators: Valerie Primeau, Wiplove Lamba, Marlon Danilewitz, Anees Bahji, Narges Beyraghi, Sumeet Dama

Session Objectives:

By the end of this session, the participant will be able to:

  1. Apply the Motivational Interviewing techniques learned in the previous session through coaching, practice and reflection
  2. Describe how to adapt the learned Motivational Interviewing techniques for complex patient presentations through coaching, practice and reflection
  3. Identify the importance of treating psychiatric co-morbidities concurrently
Speakers:
Valerie Primeau, MD, FRCPC is a bilingual psychiatrist in North Bay.  She has been actively involved in the treatment of concurrent disorders.  She assisted in the implementation of medically supervised withdrawal management beds at the North Bay Regional Health Centre (NBRHC) acute inpatient psychiatry unit, and is the physician lead for the rural implementation of the Centre for Addiction and Mental Health (CAMH) Integrated Care Pathway on alcohol use disorder and depression.  Most recently, she has been appointed the physician lead for the implementation of a Rapid Access Addiction Medicine (RAAM) clinic at the Community Counselling Centre of Nipissing.  She currently sits on the Health Quality Ontario Alcohol Use Disorder Quality Standard Advisory Committee and is helping revise the Withdrawal Management Standards with Addictions and Mental Health Ontario.  She is highly involved in resident education and is currently the North Bay Site Director, Psychotherapy Coordinator and Academic Coordinator for the Northern Ontario School of Medicine (NOSM) Psychiatry Residency Program.
Wiplove Lamba, MD, FRCPC, Dip ABAM, ISAM C, DAPN is an addiction psychiatrist at the University of Toronto.  He is a lecturer in the department of Anesthesia and an assistant professor in the department of psychiatry.  He have given over 20 workshops at the national level and numerous more at the local and provincial level in helping people build skills in working with those who use substances. He is the regional co-director of Ontario for the Canadian Society of Addiction Medicine and the medical co-lead of ECHO Ontario Addiction Medicine and Psychosocial interventions.  He is a member of the motivational interviewing network of trainers, and the education committee chair of the Ontario Psychiatric Association.   He is excited to work with all of you in teaching and learning together how to best approach people who use substances.
Dr. Anees Bahji is a 5th year resident in the Department of Psychiatry at Queen’s University, where he is concurrently pursuing an MSc in epidemiology as well as a PhD in neurosciences. His interests in addictions began in his undergraduate training, when he volunteered on the then-HIV/AIDS wards of St. Paul’s Hospital. During medical school at UBC, he completed research and clinical rotations with the BC Centre of Excellence and the St. Paul’s Hospital Addiction Medicine team, where he gained an appreciation for the complexity of addiction and its treatment. In residency, he collaborated with colleagues across multiple disciplines to launch an inpatient addictions medicine consult team (“Substance Treatment and Rehabilitation Team”) to address unmet addictions needs and provide meaningful care for admitted patients at Kingston Health Sciences Centre. He is currently pursuing addictions fellowship training.
Dr. Marlon Danilewitz, MD, is a 5th year research-track, psychiatry resident at the University of British Columbia and an American Psychiatric Association Leadership Fellow. He completed his Addiction Medicine fellowship through the BC Centre on Substance Use and his medical degree at the University of Ottawa. His clinical interests include opioid agonist therapies, concurrent disorders, and consultation liaison psychiatry. Dr Danilewitz’s research centers on the therapeutic use of brainstimulation, opioid agonist therapies and mindfulness meditation. He has strong interest in medical education and teaching, which has led him to take on the role of chief resident and co-president of the psychiatry resident body at UBC. He is an active physician leader and currently involved in the leadership of the BC Psychiatric Association and Canadian Psychiatric Association. He is the recipient of multiple local, and national awards for his research and teaching. 

 

Registration Fees:

Fee Type Cost
OPA Members – Full $195.00 + HST = $220.35
OPA Members – Associate/Life/Honorary/Inactive $145.00 + HST = $163.85
Residents $75.00 + HST = $84.75
Non-Members – Physicians $345.00 + HST = $389.85
Non-Members – Allied Health Care Professionals $165.00 + HST = $186.45

To qualify for member fees your membership should be in good standing.

How to Register

Online registration is now closed, however, on-site registrations are still available. 


© 2019 Ontario Psychiatric Association
Privacy Policy
^